rs104894521
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_ModeratePP5_Moderate
The NM_001136472.2(LITAF):c.346T>G(p.Trp116Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
LITAF
NM_001136472.2 missense
NM_001136472.2 missense
Scores
13
5
1
Clinical Significance
Conservation
PhyloP100: 6.70
Genes affected
LITAF (HGNC:16841): (lipopolysaccharide induced TNF factor) Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PM1
In a region_of_interest Membrane-binding amphipathic helix (size 23) in uniprot entity LITAF_HUMAN there are 8 pathogenic changes around while only 0 benign (100%) in NM_001136472.2
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.939
PP5
Variant 16-11553564-A-C is Pathogenic according to our data. Variant chr16-11553564-A-C is described in ClinVar as [Pathogenic]. Clinvar id is 6059.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr16-11553564-A-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LITAF | NM_001136472.2 | c.346T>G | p.Trp116Gly | missense_variant | 3/4 | ENST00000622633.5 | NP_001129944.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LITAF | ENST00000622633.5 | c.346T>G | p.Trp116Gly | missense_variant | 3/4 | 1 | NM_001136472.2 | ENSP00000483114 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Charcot-Marie-Tooth disease type 1C Pathogenic:2Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 14, 2003 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2022 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects LITAF function (PMID: 21896645, 23166352, 23359569, 23576546, 25058650). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 6059). This variant is also known as SIMPLE p.Trp116Gly. This missense change has been observed in individuals with Charcot-Marie-Tooth disease (PMID: 12525712, 15122712, 28211240). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tryptophan, which is neutral and slightly polar, with glycine, which is neutral and non-polar, at codon 116 of the LITAF protein (p.Trp116Gly). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;D;.;D;.;D;.;D;D;D;.;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;.;.;D;.;D;.;.;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;M;M;M;M;M;.;M;M;.;.;M;.;.
MutationTaster
Benign
A;A;A;A;A;A;A;A;A;A
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;.;D;D;D;.;.;.;.;.;.;.;.;.
REVEL
Pathogenic
Sift
Pathogenic
.;.;D;D;D;.;.;.;.;.;.;.;.;.
Sift4G
Pathogenic
D;D;T;D;D;D;D;D;D;.;.;T;.;T
Polyphen
D;D;.;D;.;D;.;D;D;.;.;.;.;.
Vest4
MutPred
Loss of catalytic residue at L114 (P = 0.0543);Loss of catalytic residue at L114 (P = 0.0543);Loss of catalytic residue at L114 (P = 0.0543);Loss of catalytic residue at L114 (P = 0.0543);Loss of catalytic residue at L114 (P = 0.0543);Loss of catalytic residue at L114 (P = 0.0543);.;Loss of catalytic residue at L114 (P = 0.0543);Loss of catalytic residue at L114 (P = 0.0543);Loss of catalytic residue at L114 (P = 0.0543);Loss of catalytic residue at L114 (P = 0.0543);Loss of catalytic residue at L114 (P = 0.0543);Loss of catalytic residue at L114 (P = 0.0543);Loss of catalytic residue at L114 (P = 0.0543);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at